Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H6N2O2 |
Molecular Weight | 126.1133 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CNC(=O)NC1=O
InChI
InChIKey=RWQNBRDOKXIBIV-UHFFFAOYSA-N
InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)
Molecular Formula | C5H6N2O2 |
Molecular Weight | 126.1133 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. | 2000 Jul |
|
Mechanisms and implications of the age-associated decrease in DNA repair capacity. | 2000 Jul |
|
Adenine-induced selective apoptosis toward HIV chronically infected cells in vitro. | 2000 Jul 14 |
|
Ionization mechanism of oligonucleotides in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2001 |
|
Phylogeny, function, and evolution of the cupins, a structurally conserved, functionally diverse superfamily of proteins. | 2001 Apr |
|
Association study of CAG repeats in the KCNN3 gene in Japanese patients with schizophrenia, schizoaffective disorder and bipolar disorder. | 2001 Apr 15 |
|
15-mer DNA duplexes containing an abasic site are thermodynamically more stable with adjacent purines than with pyrimidines. | 2001 Apr 3 |
|
Metastable decay of negatively charged oligodeoxynucleotides analyzed with ultraviolet matrix-assisted laser desorption/ionization post-source decay and deuterium exchange. | 2001 Feb |
|
5-Formyluracil and its nucleoside derivatives confer toxicity and mutagenicity to mammalian cells by interfering with normal RNA and DNA metabolism. | 2001 Feb 3 |
|
Mutagenic effects of 5-formyluracil on a plasmid vector during replication in Escherichia coli. | 2001 Jan |
|
The transport of a reversible proton pump antagonist, 5, 6-dimethyl-2-(4-Fluorophenylamino)-4-(1-methyl-1,2,3, 4-tetrahydroisoquinoline-2-yl) pyrimidine hydrochloride (YH1885), across caco-2 cell monolayers. | 2001 Jan |
|
Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages. | 2001 Jan 15 |
|
Conformation and dynamics of abasic sites in DNA investigated by time-resolved fluorescence of 2-aminopurine. | 2001 Jan 30 |
|
Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents. | 2001 Jan-Feb |
|
Solution structure of an A-tract DNA bend. | 2001 Mar 9 |
|
Fragmentation mechanisms of oligodeoxynucleotides: effects of replacing phosphates with methylphosphonates and thymines with other bases in T-rich sequences. | 2001 May |
|
Recognition and kinetics for excision of a base lesion within clustered DNA damage by the Escherichia coli proteins Fpg and Nth. | 2001 May 15 |
|
Insight into the catalytic mechanism of DNA polymerase beta: structures of intermediate complexes. | 2001 May 8 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:18 GMT 2023
by
admin
on
Fri Dec 15 15:00:18 GMT 2023
|
Record UNII |
QR26YLT7LT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
48157-2
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
||
|
LOINC |
75153-7
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
||
|
LOINC |
75121-4
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
||
|
NCI_THESAURUS |
C789
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
QR26YLT7LT
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
m10823
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
1135
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
65-71-4
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
168663
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
D013941
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
200-616-1
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
100000091723
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
DB03462
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
C881
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
1724532
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
QR26YLT7LT
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
17821
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
DTXSID4052342
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
THYMINE
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
1368871
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
14705
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY | |||
|
SUB27112
Created by
admin on Fri Dec 15 15:00:18 GMT 2023 , Edited by admin on Fri Dec 15 15:00:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
||
|
METABOLITE -> PARENT |
BAIBA induces energy expenditure in adipocytes and distal fat tissues, and β-oxidation of hepatic fatty acids in part via activation of peroxisome proliferators-activated receptor α (PPARα) [33]. Notably, in humans, plasma BAIBA concentrations increase with exercise and are inversely associated with metabolic risk factors.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
Amount Not Specified
INTERNATIONAL PHARMACOPEIA
|
||
|
PARENT -> IMPURITY |
Calculation of percentage contents: – correction factor: multiply the peak area of impurity A by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |